Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.38 |
| ▸ | HTR7 | P34969 | 6/20 | 0.36 |
| ▸ | HTR2B | P41595 | 6/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20204500 | 0.95 | PDK2 (0.36) | PDK2HTR7HTR2BDRD2ADRA1D | |
| SCHEMBL17345759 | 0.91 | WDR5 (0.39) | PDK2HTR7HTR2B | |
| SCHEMBL22930624 | 0.91 | WDR5 (0.39) | PDK2HTR7HTR2B | |
| SCHEMBL17345727 | 0.82 | PRSS1 (0.44) | PDK2 | |
| SCHEMBL17233969 | 0.81 | PDK2 (0.38) | PDK2HTR7HTR2BDRD2ADRA1D | |
| SCHEMBL22688593 | 0.80 | PDK2 (0.40) | PDK2HTR7HTR2B | |
| SCHEMBL15811033 | 0.80 | PDK2 (0.36) | PDK2HTR7HTR2B | |
| SCHEMBL18933880 | 0.77 | GRIN2B (0.46) | PDK2 | |
| SCHEMBL22440859 | 0.76 | PDK2 (0.61) | PDK2HTR7HTR2B | |
| SCHEMBL30951744 | 0.76 | PDK2 (0.61) | PDK2HTR7HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11588117-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2023-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11588117-B2 | Materials for electronic devices | EPHB3, EPHA3, EPHB4 | PDK2 2268/4885HTR7 3421/4885HTR2B 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.